Correlation Between Blueprint Medicines and Eyepoint Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Eyepoint Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Eyepoint Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Eyepoint Pharmaceuticals, you can compare the effects of market volatilities on Blueprint Medicines and Eyepoint Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Eyepoint Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Eyepoint Pharmaceuticals.
Diversification Opportunities for Blueprint Medicines and Eyepoint Pharmaceuticals
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Blueprint and Eyepoint is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Eyepoint Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyepoint Pharmaceuticals and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Eyepoint Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyepoint Pharmaceuticals has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Eyepoint Pharmaceuticals go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Eyepoint Pharmaceuticals
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.58 times more return on investment than Eyepoint Pharmaceuticals. However, Blueprint Medicines Corp is 1.72 times less risky than Eyepoint Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Eyepoint Pharmaceuticals is currently generating about -0.25 per unit of risk. If you would invest 8,751 in Blueprint Medicines Corp on September 1, 2024 and sell it today you would earn a total of 887.00 from holding Blueprint Medicines Corp or generate 10.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Eyepoint Pharmaceuticals
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Eyepoint Pharmaceuticals |
Blueprint Medicines and Eyepoint Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Eyepoint Pharmaceuticals
The main advantage of trading using opposite Blueprint Medicines and Eyepoint Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Eyepoint Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyepoint Pharmaceuticals will offset losses from the drop in Eyepoint Pharmaceuticals' long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |